Global EconomyEconomic Times•1 min read•10/30/2026 (3h ago)

Sun Pharma Q2 Results: Profit falls 36% YoY to Rs 1,989 crore on exceptional charges

Sun Pharma Q2 Results: Profit falls 36% YoY to Rs 1,989 crore on exceptional charges
60-Word AI Digest

Sun Pharma Q2 Results: Revenue from operations rose 12% YoY to Rs 16,199 crore from Rs 14,478 crore in Q2 of last financial year, supported by strong growth in its domestic formulations business and emerging markets.

Key Takeaways

  • Sun Pharma Q2 Results: Profit falls 36% YoY to Rs 1,989 crore on exceptional charges
  • Sun Pharma Q2 Results: Revenue from operations rose 12% YoY to Rs 16,199 crore from Rs 14,478 crore in Q2 of last financial year, supported by strong growth in its domestic formulations business and emerging markets.
  • Click full coverage link below for the complete official dispatch.

Sun Pharma Q2 Results: Revenue from operations rose 12% YoY to Rs 16,199 crore from Rs 14,478 crore in Q2 of last financial year, supported by strong growth in its domestic formulations business and emerging markets.

Original Publisher Attribution

This summary was curated from Economic Times.

Read Original on Economic Times
Sun Pharma Q2 Results: Profit falls 36% YoY to Rs 1,989 crore on exceptional charges — Loop60